TMAB Therapeutics, Inc Revenue
Biotechnology Research • 
Houston, Texas, United States • 1-10 Employees
$
TMAB Therapeutics, Inc revenue & valuation
| Annual revenue | $342,220 |
| Revenue per employee | $86,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues | $1,100,000 |
| Total funding | No funding |
Key Contact at TMAB Therapeutics, Inc
Gail Maderis
Chair of the Board of Directors
Company overview
| Headquarters | 2450 Holcombe Blvd, Houston, Texas 77021, US |
| Website | |
| NAICS | 541714 |
| Founded | 2023 |
| Employees | 1-10 |
About TMAB Therapeutics, Inc
TMAB is developing first-in-class multi-specific antibodies targeting the solid tumor micro-environment.
Employees by Management Level
Total employees: 1-10
Seniority
Employees
Director
Funding Data
TMAB Therapeutics, Inc has never raised funding before.
Sweden
United Kingdom
South Africa
Frequently asked questions
TMAB Therapeutics, Inc is located in Houston, Texas, US.
TMAB Therapeutics, Inc generates an estimated annual revenue of $342,220. This revenue figure reflects the company's market position and business performance in its industry.
TMAB Therapeutics, Inc has an estimated valuation of $1,100,000. This valuation is calculated based on industry-standard revenue multiples and reflects the company's growth potential and market positioning.
TMAB Therapeutics, Inc was founded in 2023, making it 3 years old. The company has established itself as a significant player in its industry over this time.
TMAB Therapeutics, Inc has approximately 1-10 employees. The company continues to grow its workforce to support its business operations and expansion.
4.8
40,000 users
